How to Develop a Clinical NGS Assay
Without Losing Your Mind. Or Shirt.
A genomics revolution has been underway for nearly a decade, and clinical laboratories are the catalyst.
An exponentially growing body of clinical evidence shows doctors can diagnose and treat some of the most deadly and persistent forms of cancer by looking to the genome. And as the new world of pathway-based therapeutics intersects with faster and cheaper DNA/RNA sequencing technologies, physicians, researchers, and patients are turning toward molecular pathology laboratories to lead the way.
You want to expand your use of the new diagnostic tools for your patient population. And to do so, you need to develop clinical NGS-based assays and bring them online as quickly and cost-effectively as possible.
Okay, but how? This new guide from SeraCare discusses how to develop clinical NGS-based assays, without losing your mind. Or your shirt.
Learn more about:
- The top 3 challenges facing labs in the development phase
- Advice on how many rare variants to include, and where to find them
- Controlling costs while ensuring assay performance
Fill out the form to download this white paper.